Back
AbbVie, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
59
ABBV
AbbVie, Inc.
Last Price:
$226.83
Seasonality Move:
3.6%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ABBV is experiencing slight buying pressure.
AbbVie, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 224.69 | Buy |
| 20-day SMA: | 226.56 | Buy |
| 50-day SMA: | 226.68 | Buy |
| 200-day SMA: | 205.48 | Buy |
| 8-day EMA: | 224.98 | Buy |
| 20-day EMA: | 225.8 | Buy |
| 50-day EMA: | 224.95 | Buy |
| 200-day EMA: | 209.26 | Buy |
AbbVie, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.7 | Sell |
| Relative Strength Index (14 RSI): | 51.29 | Buy |
| Chaikin Money Flow: | 4848773 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (223.82 - 231.68) | Sell |
| Bollinger Bands (100): | (208.86 - 231.52) | Buy |
AbbVie, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for AbbVie, Inc. Stock
Is AbbVie, Inc. Stock a Buy?
-
AbbVie, Inc. share price is 226.82 while ABBV 8-day simple moving average is 224.69, which is a Buy signal.
-
The stock price of ABBV is 226.82 while AbbVie, Inc. 20-day SMA is 226.56, which makes it a Buy.
-
AbbVie, Inc. 50-day simple moving average is 226.68 while ABBV share price is 226.82, making it a Buy technically.
-
ABBV stock price is 226.82 and AbbVie, Inc. 200-day simple moving average is 205.48, creating a Buy signal.
ABBV Technical Analysis vs Fundamental Analysis
Buy
59
AbbVie, Inc. (ABBV)
is a Buy
Is AbbVie, Inc. a Buy or a Sell?
-
AbbVie, Inc. stock is rated a BuyThe current AbbVie, Inc. [ABBV] share price is $226.82. The Score for ABBV is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
AbbVie, Inc. Stock Info
Market Cap:
400.9B
Price in USD:
226.82
Share Volume:
19M
AbbVie, Inc. 52-Week Range
52-Week High:
244.81
52-Week Low:
164.39
Buy
59
AbbVie, Inc. (ABBV)
is a Buy
AbbVie, Inc. Share Price Forecast
-
What is the AbbVie, Inc. stock price today?The AbbVie, Inc. stock price is 226.82 USD today.
-
Will ABBV stock go up or go down?AbbVie, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is AbbVie, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, AbbVie, Inc. is not overvalued.
Is AbbVie, Inc. Stock a Buy?
-
AbbVie, Inc. share price is 226.82 while ABBV 8-day exponential moving average is 224.98, which is a Buy signal.
-
The stock price of ABBV is 226.82 while AbbVie, Inc. 20-day EMA is 225.80, which makes it a Buy.
-
AbbVie, Inc. 50-day exponential moving average is 224.95 while ABBV share price is 226.82, making it a Buy technically.
-
ABBV stock price is 226.82 and AbbVie, Inc. 200-day simple moving average is 209.26, creating a Buy signal.
Fundamental Analysis of AbbVie, Inc.
Is AbbVie, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.47 per share, and an increase next year of $3.61 per share.
Technical Analysis of AbbVie, Inc.
Should I short AbbVie, Inc. stock?
-
ABBV Moving Average Covergence Divergence (MACD) indicator is -0.7, suggesting AbbVie, Inc. is a Sell
-
AbbVie, Inc. Relative Strength Index (RSI) is 51.29, which suggest AbbVie, Inc. is overbought
-
The Bollinger Bands (25) for AbbVie, Inc. is (223.82 - 231.68), which suggest AbbVie, Inc. is a Buy
-
The Bollinger Bands (100) for AbbVie, Inc. is (208.86 - 231.52), which suggest AbbVie, Inc. is a Buy
* AbbVie, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.